Kala Bio (KALA) Assets (2016 - 2026)
Kala Bio (KALA) reported Assets of $10.58 million for Q2 2026, down 70.6% from $36.05 million a year earlier and down 14.1% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Kala Bio posted Assets of $9.49 million, down 82.9% from FY2024.
- Assets has declined for five consecutive years, with a five-year compound annual growth rate of -46.7% (FY2020 to FY2025).
- By year, Assets came in at $55.48 million in FY2024 (-0.8%), $55.95 million in FY2023 (-35.6%), $86.82 million in FY2022 (-37.7%) and $139.43 million in FY2021 (-37.1%).
- Five-year quarterly Assets spans a low of $9.49 million in Q4 2025 and a high of $193.81 million in Q3 2021.
- Year over year, Assets has now declined in each of the last 22 quarters, with an average decline of 43.1% over the last eight quarters.
- The year-over-year decline in Assets has ranged between 0.8% (Q4 2024) and 82.9% (Q4 2025) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $12.32 million (Q1 2026), $9.49 million (Q4 2025) and $25.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Kala Bio | 6.57 Mn | 6.57 Mn | - | 10.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.58 Mn |
| Mar 31, 2026 | 12.32 Mn |
| Dec 31, 2025 | 9.49 Mn |
| Sep 30, 2025 | 25.02 Mn |
| Jun 30, 2025 | 36.05 Mn |
| Mar 31, 2025 | 48.25 Mn |
| Dec 31, 2024 | 55.48 Mn |
| Sep 30, 2024 | 54.08 Mn |
| Jun 30, 2024 | 61.61 Mn |
| Mar 31, 2024 | 53.03 Mn |
| Dec 31, 2023 | 55.95 Mn |
| Sep 30, 2023 | 61.12 Mn |
| Jun 30, 2023 | 66.50 Mn |
| Mar 31, 2023 | 72.23 Mn |
| Dec 31, 2022 | 86.82 Mn |
| Sep 30, 2022 | 85.70 Mn |
| Jun 30, 2022 | 84.98 Mn |
| Mar 31, 2022 | 111.57 Mn |
| Dec 31, 2021 | 139.43 Mn |
| Sep 30, 2021 | 193.81 Mn |
API Access
Kala Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();